-transparent.png){kind=logo}
Anemia is a common side effect of cisplatin, especially after repeated infusions. The primary mechanisms is a myelosuppression caused by cisplatin's interference with iron metabolism, resulting in a lower count of red cell precursors. Some authors report a hemolytic anemia similar to penicillin-induced anemia, in which hemolysis is caused by an antiglobulin antibody directed against red cell membrane-bound cisplatin. The authors report two cases of cisplatin-induced anemia and suggest that the immune-complex hypothesis is responsible for hemolysis. The first case of carboplatin-induced hemolysis is also reported. Mechanisms of hemolysis and clinical practice are discussed.
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
August 2010,
World journal of oncology,
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
January 1996,
Transfusion,
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
December 2015,
Transfusion,
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
January 2022,
Frontiers in medicine,
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
September 1967,
Il Policlinico. Sezione pratica,
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
January 1991,
Yao xue xue bao = Acta pharmaceutica Sinica,
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
August 1975,
JAMA,
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
February 1991,
Transfusion,
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
September 2008,
Transfusion,
F Maloisel, and
J E Kurtz, and
E Andres, and
C Gorodetsky, and
P Dufour, and
F Oberling
September 1989,
Cancer,
